Wuhan Boren Kairun Pharmaceutical Co., Ltd.‌ is a high-tech enterprise established on September 25, 2013, specializing in the research and development and production of ‌intermediates for targeted drug delivery systems‌. The company is headquartered at Room S307, Zone B, Free Trade Biotech Innovation Park, No. 777 Guanggu 3rd Road, East Lake High-Tech Development Zone, Wuhan, Hubei Province.

The current legal representative is ‌Yang Feng‌, with a registered capital of 5 million RMB. The company is active and classified as a micro-sized technology enterprise in the chemical raw materials and chemical products manufacturing industry. Its main business covers R&D, technology transfer, and technical services in food, health products, biotechnology, pharmaceuticals, and medical devices.

Core Business and Products

• ‌Main Products‌: Mass production of internationally popular PEG LINKER compounds (e.g., CAS 101187-39-7 Azide-Tetraethylene Glycol-Azide), used in the development of antibody-drug conjugates (ADCs) and other targeted therapies.

• ‌R&D Focus‌: Development of PEG-modified nanolipid formulations and lipophilic nanoparticle formulation materials, serving personalized anticancer drug delivery systems.

• ‌Technological Innovation‌: Holds ‌16 patents‌, including devices for chemical reagent storage and heating apparatus for polyethylene glycol production, and has mastered the " Drug Delivery Technology."